We developed scEpi2-seq, a single-cell method which jointly profiles DNA methylation and histone modifications from the same DNA molecule. This multi-omic strategy reveals how chromatin context influences the maintenance of DNA methylation and identifies distinct epigenomic signatures across cell types in both cultured and primary tissues.